Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Olema Pharmaceuticals, Inc. (OLMA) had Debt to Equity Ratio of 0.01 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-46.06M |
|
-- |
|
-- |
|
$50.08M |
|
$-50.08M |
|
$4.02M |
|
$-46.06M |
|
$-46.06M |
|
$-46.06M |
|
$-46.06M |
|
$-46.06M |
|
$-46.06M |
|
$-50.08M |
|
$-49.90M |
|
87.01M |
|
87.01M |
|
$-0.51 |
|
$-0.51 |
|
| Balance Sheet Financials | |
$515.45M |
|
-- |
|
$17.98M |
|
$533.43M |
|
$51.80M |
|
$3.00M |
|
$3.07M |
|
$54.87M |
|
$478.56M |
|
$478.56M |
|
$478.56M |
|
81.38M |
|
| Cash Flow Statement Financials | |
$-146.72M |
|
$-155.76M |
|
$211.30M |
|
$139.48M |
|
$48.30M |
|
$-91.18M |
|
$17.59M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.95 |
|
-- |
|
-- |
|
0.01 |
|
|
Debt to Equity Ratio |
0.01 |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-146.72M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-9.62% |
|
-9.62% |
|
-8.63% |
|
-9.56% |
|
$5.88 |
|
$-1.69 |
|
$-1.69 |
|